Aurinia Pharmaceuticals
AUPH
AUPH
62 hedge funds and large institutions have $147M invested in Aurinia Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
61% less call options, than puts
Call options by funds: $2.15M | Put options by funds: $5.56M
Holders
62
Holding in Top 10
–
Calls
$2.15M
Puts
$5.56M
Top Buyers
| 1 | +$2.73M | |
| 2 | +$1.25M | |
| 3 | +$461K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$377K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$326K |
Top Sellers
| 1 | -$1.56M | |
| 2 | -$1.29M | |
| 3 | -$598K | |
| 4 |
Bank of New York Mellon
New York
|
-$502K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$387K |